Uttam Sharma
发表
A. Bishayee,
Aklank Jain,
S. Shekhar,
2021,
International journal of molecular sciences.
Aklank Jain,
H. Prakash,
H. Tuli,
2022,
Pharmacological research.
Aklank Jain,
K. Sak,
V. Aggarwal,
2021,
Critical reviews in oncology/hematology.
Harmanpreet Singh Kapoor,
Aklank Jain,
Priyanka Madaan,
2023,
Frontiers in medicine.
Aklank Jain,
T. S. Barwal,
U. Sharma,
2022,
Translational oncology.
K. Vasquez,
Aklank Jain,
Lovlesh Thakur,
2019,
Biochimie.
M. Kumar,
Aklank Jain,
V. Garg,
2022,
Toxicology reports.
E. Imyanitov,
K. Vasquez,
Aklank Jain,
2021,
Biochimie.
K. Vasquez,
Aklank Jain,
H. Prakash,
2020,
Biochimie.
Aklank Jain,
A. Sharma,
R. Yadav,
2022,
International journal of cancer.
Aklank Jain,
R. Yadav,
H. Prakash,
2021
.
A. Bishayee,
Aklank Jain,
N. Pant,
2022,
Biomarkers in medicine.
K. Vasquez,
Aklank Jain,
N. Pant,
2020,
Life sciences.
Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer Treatment
K. Vasquez,
Aklank Jain,
T. S. Barwal,
2020,
Translational oncology.
A. Bishayee,
Aklank Jain,
Manju Jain,
2022,
Current oncology.
A. Bishayee,
Manoj Kumar,
Aklank Jain,
2019,
Front. Pharmacol..
G. Sethi,
Aklank Jain,
T. Behl,
2022,
Translational oncology.
K. Vasquez,
Aklank Jain,
R. Seam,
2021,
Frontiers in Oncology.
M. Kumar,
Aklank Jain,
J. Kaur,
2021,
Experimental biology and medicine.
Aklank Jain,
T. S. Barwal,
M. Rana,
2022,
International journal of breast cancer.
K. Vasquez,
Aklank Jain,
H. Prakash,
2019,
Front. Oncol..
Harmanpreet Singh Kapoor,
Aklank Jain,
Manju Jain,
2022,
Critical reviews in oncology/hematology.
Aklank Jain,
A. Kaur,
U. Sharma,
2021,
Nutrition and cancer.
Aklank Jain,
M. Rana,
Vivek Uttam,
2023,
Biomarkers in medicine.
G. Sethi,
Ajay Mahaputra Kumar,
Aklank Jain,
2023,
Environmental research.
Aklank Jain,
V. Garg,
M. Yerer,
2022,
Molecular Biology Reports.
Aklank Jain,
R. Chhabra,
T. S. Barwal,
2022,
Clinical Applications of Non-Coding RNAs in Cancer.
A. Bishayee,
Aklank Jain,
Karuna Singh,
2020,
International journal of molecular sciences.
The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer
Manju Jain,
H. Tuli,
Vivek Uttam,
2024,
Cell death discovery.